Medarex, Inc.
(NASDAQ:MEDX)|
5.25 -0.14 (-2.60%) Jan 07 - Close |
|
|
|
After-Hours 5.27 +0.02 (0.38%) Wed, 7 Jan 2009 7:40 PM
- Compare MEDX with:
- View: Line | Candlestick
Company Profile
Medarex, Inc.
707 State Road
Princeton, NJ 08540
United States - Map
Phone: (609) 430-2880
Fax: (609) 430-2850
Website: www.medarex.com
State of incorporation: New Jersey
CEO: Howard H. Pien
Employees: 500
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
We are a biopharmaceutical company
A biopharmaceutical company, focuses on the discovery, development and commercialization of human antibody-based therapeutic product candidates.
Recent news for MEDX
-
Medarex to Present at the 27th Annual J.P. Morgan Healthcare Conference
PR Newswire - Jan 06 at 4:00 ET
-
Biotech Mailbag: Bad CEOs Offer Lessons
TheStreet.com - Dec 19 2008 at 11:08 ET
-
Briefing.com - Dec 15 2008 at 12:23 ET
-
PR Newswire - Dec 15 2008 at 12:22 ET
-
MEDAREX INC Files SEC form 8-K, Other Events
EDGAR Online - Dec 12 2008 at 4:25 ET
-
TheStreet.com - Dec 10 2008 at 6:59 ET
-
Briefing.com - Dec 08 2008 at 8:03 ET
-
PR Newswire - Dec 08 2008 at 8:00 ET
-
Medarex to Present at the RBC Capital Markets Healthcare Conference
PR Newswire - Dec 03 2008 at 7:00 ET
-
Three-Month, Updated FDA Decision Calendar
Seeking Alpha - Dec 01 2008 at 5:23 ET
Member sentiment (?) Neutral
Recent opinions on MEDX
-
FDA Calendar: High Hopes for Amgen's Bone Drug
Dec 25 2008 at 10:17 ET (By MikeHavRx)